| |  | | | | By Katie Palmer and Mario Aguilar Molly Ferguson for STAT The FDA has been largely secretive about how it determines which medical devices should receive breakthrough designation. Read More | | By Patrick Skerrett This week's "First Opinion Podcast" explores the "ineffective" and "inequitable" ways that many nursing homes care for their residents. Read More | | By Ed Silverman Pfizer Pfizer is arguing that its IP is a human right that would be violated if the Dominican Republican issues a compulsory license for Paxlovid. Read More | | Sponsor content by STAT Events Copy of Battle scars: The journey from lab to patient's bedside Join STAT on May 3 in Boston to explore the challenges, and the unique opportunities for new approaches, solutions, and partnerships, of the drug development process. This in-person program will bring together a diverse group of individuals to share their perspectives about the drug development process. Stay once the conversation is complete for a networking and cocktail reception with STAT and your fellow attendees. Get your ticket now (and save 40% as a STAT+ subscriber). | | By Benjamin F. Miller Adobe Lack of support and funding jeopardizes the rollout of 988, the new nationwide mental health and suicide prevention crisis hotline. Read More | | By Gideon Gil Hear from a researcher from the 2022 STAT Madness winning team discuss their work, its potential impact, and what's next in their field. Read More | |
No comments